These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21255579)

  • 1. Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.
    Wang QJ; Hanada K; Feldman SA; Zhao Y; Inozume T; Yang JC
    J Immunol Methods; 2011 Mar; 366(1-2):43-51. PubMed ID: 21255579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas.
    Wang QJ; Hanada K; Yang JC
    J Immunol; 2008 Sep; 181(6):3769-76. PubMed ID: 18768829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
    Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
    Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptor.
    Hanada K; Wang QJ; Inozume T; Yang JC
    Blood; 2011 May; 117(18):4816-25. PubMed ID: 21300979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.
    Puisieux I; Bain C; Merrouche Y; Malacher P; Kourilsky P; Even J; Favrot M
    Int J Cancer; 1996 Apr; 66(2):201-8. PubMed ID: 8603812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
    Barisic S; Brahmbhatt EM; Cherkasova E; Spear TT; Savani U; Pierre S; Scurti GM; Chen L; Igboko M; Nadal R; Zeng G; Parry G; Stroncek DF; Highfill S; Dalheim AV; Reger R; Nishimura MI; Childs RW
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39266213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
    Chinnasamy N; Wargo JA; Yu Z; Rao M; Frankel TL; Riley JP; Hong JJ; Parkhurst MR; Feldman SA; Schrump DS; Restifo NP; Robbins PF; Rosenberg SA; Morgan RA
    J Immunol; 2011 Jan; 186(2):685-96. PubMed ID: 21149604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy.
    Andersen R; Westergaard MCW; Kjeldsen JW; Müller A; Pedersen NW; Hadrup SR; Met Ö; Seliger B; Kromann-Andersen B; Hasselager T; Donia M; Svane IM
    Cancer Immunol Res; 2018 Feb; 6(2):222-235. PubMed ID: 29301752
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
    Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
    Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic mutagenesis of TCR complementarity-determining region 3 residues: a single conservative substitution dramatically improves response to both multiple HLA-DR alleles and peptide variants.
    Brawley JV; Concannon P
    J Immunol; 1999 Nov; 163(9):4946-52. PubMed ID: 10528198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy.
    D'Apice L; Cuccaro F; Varriale S; Cipria D; Sartorius R; Circosta P; Cignetti A; Salerno M; Coscia MR; Oreste U; Marzullo VM; Martini G; Acuto O; De Berardinis P
    J Immunother; 2019 May; 42(4):97-109. PubMed ID: 30865026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
    Schendel DJ; Gansbacher B; Oberneder R; Kriegmair M; Hofstetter A; Riethmüller G; Segurado OG
    J Immunol; 1993 Oct; 151(8):4209-20. PubMed ID: 8409397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
    Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W
    Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.
    Zhou X; Jun DY; Thomas AM; Huang X; Huang LQ; Mautner J; Mo W; Robbins PF; Pardoll DM; Jaffee EM
    Cancer Res; 2005 Feb; 65(3):1079-88. PubMed ID: 15705910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells.
    Meijer SL; Dols A; Urba WJ; Hu HM; Smith II JW; Vetto J; Wood W; Doran T; Chu Y; Sayaharuban P; Alvord WG; Fox BA
    J Immunother; 2002; 25(4):359-72. PubMed ID: 12142559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
    Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
    J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
    Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
    Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
    Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
    J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.